SCHEMBL6396141

SCHEMBL6396141

CC(CCc1c(O)cccc1OP(=O)(O)O)c1ccc(O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.40
INPPL1 O15357 3/20 0.39
INPP5A Q14642 3/20 0.39
INPP5B P32019 2/20 0.39
HTR2C P28335 2/20 0.35
HTR2B P41595 2/20 0.35
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
NFKB1 P19838 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
HTR1A P08908 1/20 0.33
SRC P12931 3/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
PDE3A Q14432 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398534 0.88 HTR2A (0.39) HTR2AINPPL1INPP5AINPP5BHTR2C
SCHEMBL6397834 0.87 ESR1 (0.43) HTR2AINPPL1INPP5AINPP5BHTR2C
SCHEMBL6402955 0.85 ESR1 (0.35) HTR2AINPPL1INPP5AINPP5BESR1
SCHEMBL6395806 0.81 ESR1 (0.37) HTR2AHTR2BESR1ESR2NFKB1
SCHEMBL6397699 0.79 INPPL1 (0.45) HTR2AINPPL1INPP5AINPP5BHTR2B
SCHEMBL6395801 0.78 ESR1 (0.35) ESR1ESR2MIFHDAC4HDAC2
SCHEMBL6396000 0.78 ESR1 (0.46) HTR2AINPPL1INPP5AINPP5BHTR2C
SCHEMBL6394492 0.77 HTR2A (0.36) HTR2AINPPL1INPP5AINPP5BHTR2C
SCHEMBL6401534 0.77 HTR2A (0.39) HTR2AINPPL1INPP5AINPP5BESR1
SCHEMBL6396578 0.77 F2 (0.41) HTR2AINPPL1INPP5AINPP5BESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed
EP-1175425-A2 INHIBITORS OF INTESTINAL APICAL MEMBRANE NA/PHOSPHATE CO-TRANSPORTATION THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2002-01-30 EP disclosed
WO-2000043402-A2 INHIBITORS OF INTESTINAL APICAL MEMBRANE NA/PHOSPHATE CO-TRANSPORTATION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HTR2A 2756/4885INPPL1 82/4885INPP5A 158/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 HTR2A 2925/4885INPPL1 85/4885INPP5A 190/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HTR2A 2756/4885INPPL1 82/4885INPP5A 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.